Sonia Zumalave is a PhD student whose current work focuses on identifying new mutational processes mediated by retrotransposons in cancer. In particular, she will focus on the identification of functional alterations that involve changes in gene expression mediated by long-range interactions.
“Cancer has become one of the major health problems humanity is facing. However, cancer is not a unique disease, but millions. That is why nowhere but in oncology is the challenge of precision medicine more essential. Said that, I have no doubt I want to devote my scientific career to expediting progress toward precision oncology.”
2018-present: PhD in Molecular Medicine at University of Santiago de Compostela, Spain.
2016-2017: MSc. in Biomedical Research at Pompeu Fabra University, Spain:
2012-2016: BSc. in Biotechnology at University of Barcelona, Spain:
Zumalave, S. et al. Reprogramming to pluripotency of cells from a long-lived and cancer resistant blind mole-rat. Poster presentation at the Bio-Integra Saúde (BIS) National Conference, Spain, 2016.